Source: The Breast. Unidade: FM
Subjects: BIOMARCADORES, CARCINOMA, NEOPLASIAS MAMÁRIAS, IMUNOHISTOQUÍMICA
ABNT
MASILI-OKU, Sergio Mitsuo et al. Lymphocyte-predominant triple-negative breast carcinomas in premenopausal patients: Lower expression of basal immunohistochemical markers. The Breast, v. 31, p. 34-39, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.breast.2016.10.012. Acesso em: 05 set. 2024.APA
Masili-Oku, S. M., Almeida, B. G. L. de, Bacchi, C. E., Filassi, J. R., Baracat, E. C., & Carvalho, F. M. (2017). Lymphocyte-predominant triple-negative breast carcinomas in premenopausal patients: Lower expression of basal immunohistochemical markers. The Breast, 31, 34-39. doi:10.1016/j.breast.2016.10.012NLM
Masili-Oku SM, Almeida BGL de, Bacchi CE, Filassi JR, Baracat EC, Carvalho FM. Lymphocyte-predominant triple-negative breast carcinomas in premenopausal patients: Lower expression of basal immunohistochemical markers [Internet]. The Breast. 2017 ; 31 34-39.[citado 2024 set. 05 ] Available from: https://doi.org/10.1016/j.breast.2016.10.012Vancouver
Masili-Oku SM, Almeida BGL de, Bacchi CE, Filassi JR, Baracat EC, Carvalho FM. Lymphocyte-predominant triple-negative breast carcinomas in premenopausal patients: Lower expression of basal immunohistochemical markers [Internet]. The Breast. 2017 ; 31 34-39.[citado 2024 set. 05 ] Available from: https://doi.org/10.1016/j.breast.2016.10.012